Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

Pharma deals during November 2012

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

- PMLiVE

Boehringer talks More Health on new blog

Pharma company's US team looks to connect with 'social entrepreneurs'

- PMLiVE

Lundbeck and Takeda submit depression drug for US approval

Brintellix could help Lundbeck overcome loss of patent protection for Lexapro/Cipralex

- PMLiVE

Gilead expands in cancer with $510m YM BioSciences deal

Lands JAK inhibitor CYT387

- PMLiVE

Hanover appoints new associate director

Jim Baxter joins from Tonic Life to lead market access and brand communications

- PMLiVE

Lilly plans another trial for Alzheimer’s hope solanezumab

Presses on with another late-stage study for the drug

- PMLiVE

Roche invests €200m in Munich biotech centre

Creates new jobs with expansion of German diagnostic production

- PMLiVE

Word games: ditching the marketing jargon

Phil Bartlett on why he’s an advocate of ditching the jargon… choose your words carefully when you next see him!

- PMLiVE

First wave of CCGs authorised

New NHS groups will serve 10 million people

- PMLiVE

India revokes patent on Merck asthma drug

Cipla breaks one more of the pharma company's patents

Dr Thom hands comms brief to Journalista

Will provide B2B and B2C support

Forest Labs launches COPD drug Tudorza in US

Enters a market dominated by Boehringer and Pfizer's Spiriva and GSK's Advair

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links